Despite Flat Q2, Sanofi Foresees Growth In H2, Fuelled by IO And Rare Blood Units

SC1807_Bizman Telescope_662264896_1200.jpg
Sanofi CEO Sees Growth Coming, Boosted By Ablynx and Bioverativ Buys • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Business